Related Experiment Video
Updated: Feb 28, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Three-layered polyplex as a microRNA targeted delivery system for breast cancer gene therapy
Yan Li1, Yu Dai2, Xiaojin Zhang2
1State Key Laboratory of Military Stomatology, Department of Prosthodontics, School of Stomatology, the Fourth Military Medical University, Xi'an 710032, People's Republic of China.
Abstract:
MicroRNAs (miRNAs), small non-coding RNAs, play an important role in modulating cell proliferation, migration, and differentiation. Since miRNAs can regulate multiple cancer-related genes simultaneously, regulating miRNAs could target a set of related oncogenic genes or pathways. Owing to their reduced immune response and low toxicity, miRNAs with small size and low molecular weight have become increasingly promising therapeutic drugs in cancer therapy. However, one of the major challenges of miRNAs-based cancer therapy is to achieve specific, effective, and safe delivery of therapeutic miRNAs into cancer cells. Here we provide a strategy using three-layered polyplex with folic acid as a targeting group to systemically deliver miR-210 into breast cancer cells, which results in breast cancer growth being inhibited.
Insights
This study developed a targeted delivery system for microRNAs (miRNAs) to inhibit breast cancer growth. The novel three-layered polyplex effectively delivered miR-210 into cancer cells, reducing tumor progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs crucial for regulating cell functions like proliferation and differentiation.
- miRNAs offer therapeutic potential in cancer by targeting multiple oncogenic genes simultaneously.
- Challenges in miRNA therapy include achieving specific, effective, and safe delivery into cancer cells.
Purpose of the Study:
- To develop a targeted delivery strategy for therapeutic microRNAs in cancer therapy.
- To systemically deliver miR-210 specifically to breast cancer cells.
- To evaluate the efficacy of this delivery system in inhibiting breast cancer growth.
Main Methods:
- A three-layered polyplex nanoparticle system was engineered for miRNA delivery.
- Folic acid was incorporated as a targeting moiety to direct nanoparticles to cancer cells.
- The system was used to deliver miR-210 into breast cancer cells in vivo.
Main Results:
- The polyplex system successfully achieved systemic delivery of miR-210 to breast cancer cells.
- Targeted delivery of miR-210 resulted in significant inhibition of breast cancer growth.
- The strategy demonstrated specificity and effectiveness in preclinical models.
Conclusions:
- Targeted delivery of miRNAs using engineered polyplexes is a promising strategy for cancer therapy.
- This approach overcomes key challenges in miRNA delivery, enhancing therapeutic potential.
- The folic acid-targeted polyplex system offers a safe and effective method for inhibiting breast cancer progression.
More Related Videos
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
07:32Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Related Concept Videos
MicroRNAs
MicroRNAs
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Targeted Cancer Therapies
There are several types of targeted therapies against...